Alligator Bioscience AB

Alligator Bioscience AB is a biotechnology company based in Sweden, focusing on the discovery and development of innovative immuno-oncology antibody-based drugs for cancer treatment. The primary function of the company is to harness the body's immune system to fight cancer by developing therapeutic antibodies that target immune pathways critical for effective anti-tumor immune responses. Alligator Bioscience AB is known for its proprietary technology platforms like FIND®, which optimizes protein interaction, allowing the creation of next-generation bispecific antibodies designed to enhance immune-mediated tumor eradication. The company plays a crucial role in advancing oncology therapeutics, contributing to the broader biopharmaceutical industry's push toward more targeted and personalized cancer treatments. As a publicly traded entity, Alligator Bioscience AB impacts both the healthcare and life sciences industries, innovating within the competitive space of cancer treatment and striving to bring transformative therapies to market.